articleEuropean Journal of CancerApr 14, 2016Closed access

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

LHLars HofmannAFAndrea ForschnerCLCarmen LoquaiSMSimone M. GoldingerLZLisa Zimmer

Friedrich-Alexander-Universität Erlangen-Nürnberg · Universitätsklinikum Erlangen · +15 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

646
total citations
FWCI
45.59
Percentile
100%
References
51
Citations per year

Authors

28

Topics & keywords

Topics
Keywords
  • Nivolumab
  • Medicine
  • Pembrolizumab
  • Ipilimumab
  • Side effect (computer science)
  • Gastrointestinal tract
  • Endocrine system
  • Adverse effect
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.